1. P247 Umeclidinium/vilanterol (UMEC/VI) versus mono-bronchodilator therapy in steroid-free GOLD B patients with chronic obstructive pulmonary disease (COPD): the EMAX trial. (December 2018) Authors: Jones, PW; Maltais, F; Kerwin, E; Bjermer, L; Watkins, ML; Tombs, L; Naya, I; Boucot, I; Lipson, D; Compton, C Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗